Analyst Ratings for Rosetta Genomics (ROSG) [Buys]
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/8/2016 | Aegis Capital » Updated 1/4/2017 |
N/A | New Coverage | Buy (N/A) |
3.50 (N/A) |
1.08 (0.43) |
-60.19% | Details |
| 12/18/2015 | Cantor Fitzgerald | N/A | New Coverage | Spec. Buy (N/A) |
N/A (N/A) |
1.24 (0.43) |
-65.32% | Details |
